Global Medical REIT Focuses on Growth and Stability
TipRanks (Fri, 15-Nov 4:58 PM ET)
Global Medical REIT Announces Third Quarter 2024 Financial Results
Business Wire (Wed, 6-Nov 4:05 PM ET)
Global Medical REIT Inc. Announces Dates for Third Quarter Earnings Release and Webcast
Business Wire (Wed, 16-Oct 4:15 PM ET)
Global Medical REIT Announces Lease with CHRISTUS Health at its Facility in Beaumont, Texas
Business Wire (Tue, 17-Sep 8:00 AM ET)
Global Medical REIT Inc. Board Declares 2024 Third Quarter Common and Preferred Dividends
Business Wire (Thu, 5-Sep 4:05 PM ET)
Global Medical REIT Inc is a Maryland corporation engaged predominantly in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to physician groups and regional and national healthcare systems. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases.
Global Medical REIT trades on the NYSE stock market under the symbol GMRE.
As of November 15, 2024, GMRE stock price declined to $8.63 with 327,255 million shares trading.
GMRE has a beta of 0.60, meaning it tends to be less sensitive to market movements. GMRE has a correlation of 0.09 to the broad based SPY ETF.
GMRE has a market cap of $566.02 million. This is considered a Small Cap stock.
Last quarter Global Medical REIT reported $34 million in Revenue and $.22 earnings per share. This fell short of revenue expectation by $-465,000 and missed earnings estimates by -$.01.
In the last 3 years, GMRE traded as high as $18.51 and as low as $7.01.
The top ETF exchange traded funds that GMRE belongs to (by Net Assets): VNQ, VTI, IWM, KBWY, VXF.
GMRE has underperformed the market in the last year with a price return of -1.8% while the SPY ETF gained +32.1%. GMRE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.1% and -5.1%, respectively, while the SPY returned +8.0% and +3.0%, respectively.
GMRE support price is $8.52 and resistance is $8.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GMRE shares will trade within this expected range on the day.